IV therapy and vitamin injections deliver nutrients directly into the bloodstream, bypassing the digestive system for rapid absorption. These treatments are used for specific medical indications such as nutrient deficiencies, malabsorption, and recovery from illness...
Acquired ptosis, or drooping of the upper eyelid, affects millions of adults and can impair both vision and appearance. Oxymetazoline 0.1% ophthalmic solution (Upneeq®) is the first FDA-approved, non-surgical therapy for acquired blepharoptosis in adults, offering...
Bimatoprost ophthalmic solution 0.03% (Latisse®) is the only FDA-approved prescription treatment for eyelash hypotrichosis, clinically proven to enhance eyelash length, thickness, and darkness through stimulation of the hair growth cycle. Since its approval in 2008...
Polidocanol, marketed as Asclera® in the United States, is an FDA-approved sclerosing agent used for the nonsurgical treatment of spider veins and reticular veins. Its efficacy and safety are supported by extensive clinical research, positioning it as a leading option...
GLP-1 and GIP agonist injectables, including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™), have transformed evidence-based medical weight loss, achieving up to 20% body weight reduction in clinical trials. Rapid weight loss can lead to...
Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and exosomes represent the forefront of regenerative injectables, offering cell-based and cell-free options for tissue repair, wound healing, and aesthetic rejuvenation. These therapies leverage autologous or...
Exosomes and bioceramic fillers represent a significant advancement in regenerative and aesthetic medicine, offering new possibilities for tissue repair, skin rejuvenation, and facial contouring. Exosomes—cell-derived vesicles—deliver bioactive signals that support...
Sculptra® (poly-L-lactic acid) is an FDA-approved biostimulatory injectable designed to restore facial and body volume by stimulating the body’s natural collagen production. Backed by extensive clinical research, Sculptra® offers gradual, long-lasting improvement in...
Hyaluronic acid (HA) dermal fillers are the leading nonsurgical solution for facial volume restoration, wrinkle correction, and soft tissue augmentation. With over 5.3 million HA filler procedures performed in the U.S. in 2023, these injectables remain the most widely...
Bio fillers—injectable substances designed for soft tissue augmentation and regeneration—are at the forefront of modern aesthetic and reconstructive medicine. Recent research (2024–2025) provides critical insights into their efficacy, safety, and optimal application....
